remsima
Celltrion’s infliximab biosimilar Remsima secures European approval in five indications
July 27, 2020Manufacturing and Production, Sales and Marketing celltrion, infliximab, pharma, remsima
The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …
FDA set to approve Remicade biosimilar
February 9, 2016Manufacturing and Production, Research and Development, Sales and Marketing Remicade, biosimilars, remsima
An FDA committee has had some positive words for Celltrion’s biosimilar candidate to Janssen/MSD’s Remicade (infliximab), concluding that the copycat biologic …
Napp launches biosimilar in UK
February 25, 2015Research and Development, Sales and Marketing Hospira, Napp, Remicade, anti-TNF biologic, biosimilar, infliximab, remsima
Napp Pharmaceuticals has launched its own biosimilar version of an anti-TNF biologic in Europe paving the way for patient access …
Latest content
Five Facts about cardiovascular disease
August 9, 2026
